Navigation Links
Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes
Date:5/27/2009

Fertility and Sterility Publishes Article Underscoring Importance of PGD Technique and Method

LIVINGSTON, N.J., May 27 /PRNewswire/ -- A group of fertility experts, who pioneered the development of Preimplantation Genetic Screening (PGS), are sharing the step-by-step best practices and explaining what errors can be made along the way.

The article, published in the latest edition of Fertility and Sterility, details when PGS should be used, emphasizes proper embryo biopsy technique and reveals the most common errors made with the ultimate goal of educating clinics, embryologists and other experts to improve pregnancy outcomes.

When done correctly, PGS can be used to improve the success of in vitro fertilization (IVF) for women of advanced maternal age and recurrent pregnancy loss. Research shows that many times IVF fails because a majority of embryos created in vitro are chromosomally abnormal. When done correctly, PGS screens the most important chromosomes in terms of preimplantation aneuploidy (22, 16, 21 and 15), improving implantation rates.

Dr. Santiago Munne, of Reprogenetics, LLC. in Livingston, NJ, who has performed close to 15 thousand PGS cases, says this article is a must-read in any center that performs PGS.

"This article is the result of years of research and refining the PGS technique that have allowed us to achieve the success rates that we have seen," says Dr. Munne. "The techniques and technology described in this paper are required in order to improve successful pregnancy outcomes."

The article gives explicit detail about each step of the PGS process including opening the zona pellucida, removing the cell, cell fixation, how many chromosomes should be analyzed, and error rate criteria. As previous studies have shown, improper technique as well as inexperienced technicians or inadequate training, can lead to extremely increased error r
'/>"/>

SOURCE Reprogenetics, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Newly Published Phase III Study Shows Arzoxifene Significantly Increased Bone Mineral Density
2. Schering-Ploughs Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
3. BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
4. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
5. Newly Released Data on Onset of Effect and Patient Perception With SYMBICORT in Adults With Asthma
6. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
7. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
8. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
9. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
10. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
11. Newly Approved HIV Drug Shows Great Promise

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...XTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGrou...lara report,thefirstinamulti-phasesyndicatedmarke...iotech,sStelara,fromproductlaunchthroughthefirstsi...uantitativeinformationfrom75uniqueDermatologistsan...ssesstrialanduseofStelara,obstaclestouse,typicalpa...
(Date:11/25/2009)...ANCHOCORDOVA,Calif.,Nov.25/PRNewswire/--AMPACFineC...ration(Nasdaq: APFC )announcedtodaythatitreceivedt...dattheAnnualStatewideEnvironmentalSummit,sponsored...on(CMTA),theIndustrialEnvironmentalAssociation(IEA...ldinSanDiego.Thisisthemostprestigiousawardavailabl...
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, MammographyEquipment-AGlobalMarketP...164330/Mammography-Equipment---A-Global-Market-Per...inindustrializedaswellasdevelopingnationsisaprinci...lobally,escalatingawarenessaboutbreastcancerhasall...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7U S Students Academic Interests Tend to Wane in Middle School 51812 1U S Students Academic Interests Tend to Wane in Middle School 51812 2Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer 51807 1Centocor Ortho Biotech Statement on the FDA ODAC Opinion Regarding Trabectedin for Relapsed Ovarian Cancer 51807 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 1STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 3
...indings Suggest Improved Outcomes in Carotid,Arter...ewswire-FirstCall/ --,Positive 30-day results from...can be performed with positive results by,physicia...-world,(non-clinical trial) settings in patients w...im results from the first 1,500,patients enrolled ...
...27, 2007 /PRNewswire-FirstCall/ -- Bioponic,Phytoc... announced,that its Curecumin(TM) (a Bioresonant P...cumin in a liquid nasal delivery system) may,be an...t study published in Science Direct, "Induction of..." conducted at the,Department of Medicine, Pediatr...
Other Medicine Technology:Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 2Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 3Two Abbott Studies Reaffirm Carotid Artery Stenting as a Safe and,Effective Treatment to Reduce Risk of Stroke 4Curecumin May Be an Effective Treatment for Lung Cancer 2
(Date:11/27/2009)...SANFRANCISCO,Nov.27/PRNewswire-FirstCall/--TheGymb...mbert,CFO/COO,willpresentattheNASDAQOMX23rdInvesto...England,onWednesday,December2,2009,at11:45a.m.GMT....ation,spresentationovertheInternet,pleaselogontoww...page,goto"InvestorandMediaRelations"andthen"Confer...
(Date:11/27/2009)...KIBBUTZSHAMIR,Israel,Nov.27/PRNewswire-FirstCall/-..." ),aleadingproviderofinnovativeproductsandtechnol...boardofdirectorshaddeclaredadividenddistributionin....62millionbasedontheNovember25,2009representativer...lyNIS2.3basedontheNovember25,2009representativerat...
(Date:11/27/2009)...rates to bring unprecedented medical, economic bur... (HealthDay News) -- The number of people with dia...ver the next 25 years, a new study predicts. , ...illion people with the disease, up from 23.7 milli...ting people with diabetes will triple, the study a...
(Date:11/27/2009)... Multi-purpose bilingual coloring...d for use by the business community to educate - i...ubjects from Safety issues to Dinosuars to ABC,S a... Saint Louis, MO (PRWEB) November 27, 2009 -- T...nics or toys to keep them busy any hour of the day...
(Date:11/26/2009)...NEWYORK,Nov.27/PRNewswire/--Withcoldandfluseasonup...stocontrolthespreadofinfectionsandavoidillness. ,...thy,buttoavoidtransmittingillnessifwe,resick,"said...ol),nursingdirectorforinfectioncontrolandoccupatio...an. ,, HospitalforSpecialSurgeryhasoneofthelowe...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3
...ns University has received a $4.97 million grant f...ke the initial phase of a unique program aimed at ...a, in coordination with the Johns Hopkins Center f...sing, and public health at both schools will devel...
...1 Serotek Corporation, the leading,provider of in...are and,services, today released version 3.0 of it... release, Serotek now offers the first full-featur...nals,alike. , Blind information technology p...
...or difficult to diagnose patients,Breast-Specific ...adjunctive,imaging tool than ultrasound for patien...nable mammogram, this according to findings presen... independent,of tissue density and discover very e...
... Dec. 1 Vapotherm, the global leader in High Flow...sident and CEO, Robert Storey, will present at Pip...esday, December 3rd at 1:30 PM at the New York Pal...trends, advances, challenges and opportunities in ...
...., Dec. 1 EMS Magazine, the leading,monthly publi...recently,announced the winners of the EMS EXPO 200...he industry,s most innovative products of the year...Texas EMS,State Conference in Fort Worth, TX, Nove...
...., Dec. 1 Pressure BioSciences, Inc. (Nasdaq: P...omprehensive restructuring program designed to sig...s, and refocus the Company,s business strategy in ...personnel of eight full-time employees (40% of the...
Other Medicine News:Health News:Johns Hopkins and Makerere University to collaborate on African health education initiative 2Health News:Johns Hopkins and Makerere University to collaborate on African health education initiative 3Health News:Serotek First to Offer 64-Bit Support 2Health News:Molecular Breast Imaging Performs Better Than Ultrasound in Patients With Mammographic Abnormalities 2Health News:EMS Magazine Announces Top Innovation Awards for 2008 2Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 2Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 3Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 4Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 5Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 6Health News:Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus 7
... is a foldable silicone IOL. It features a 6.0-mm ...ted with The UNFOLDER® Silver-T Implantation S...and only FDA-approved multifocal IOL, and the firs...ionnear, intermediate, and far. The ARRAY® Mul...
BioLon
... Methylcellulose solution that is especially well ...small incision surgery. The low molecular weight o...th minimal risk of elevated intraocular pressure. ...w of the surgical field throughout capsulorhexis a...
...tic agent for the surgeon who performs cataract su... possesses sufficient viscosity for excellent cham...hly cohesive so that complete removal at the end o...isc is priced to compete with any sodium hyalurona...
Medicine Products: